Home Other Building Blocks 5-(Pyridin-4-yl)-1,3,4-thiadiazol-2-amine

5-(Pyridin-4-yl)-1,3,4-thiadiazol-2-amine

CAS No.:
2002-04-2
Catalog Number:
AG002CM8
Molecular Formula:
C7H6N4S
Molecular Weight:
178.2143
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
96%
In Stock USA
United States
$25
- +
5g
96%
In Stock USA
United States
$107
- +
10g
96%
In Stock USA
United States
$207
- +
25g
96%
In Stock USA
United States
$463
- +
100g
96%
In Stock USA
United States
$1225
- +
Product Description
Catalog Number:
AG002CM8
Chemical Name:
5-(Pyridin-4-yl)-1,3,4-thiadiazol-2-amine
CAS Number:
2002-04-2
Molecular Formula:
C7H6N4S
Molecular Weight:
178.2143
MDL Number:
MFCD00473692
IUPAC Name:
5-pyridin-4-yl-1,3,4-thiadiazol-2-amine
InChI:
InChI=1S/C7H6N4S/c8-7-11-10-6(12-7)5-1-3-9-4-2-5/h1-4H,(H2,8,11)
InChI Key:
KTWDTPBHCWJWGJ-UHFFFAOYSA-N
SMILES:
Nc1nnc(s1)c1ccncc1
Properties
Complexity:
148  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
178.031g/mol
Formal Charge:
0
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
178.213g/mol
Monoisotopic Mass:
178.031g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
92.9A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.6  
Literature
Title Journal
Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase. Journal of medicinal chemistry 20110113
5-(3-Pyrid-yl)-1,3,4-thia-diazol-2-amine. Acta crystallographica. Section E, Structure reports online 20090601
5-(4-Pyrid-yl)-1,3,4-thia-diazol-2-amine. Acta crystallographica. Section E, Structure reports online 20090501
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Properties